Treatment Strategies and Risk of Recurrence in Patients with Heart Valve Prosthesis, Staphylococcus aureus Bacteremia, and Possible Endocarditis - A Retrospective Cohort Study

1Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Patients with heart valve prosthesis (HVP) and Staphylococcus aureus bacteremia (SAB) are at risk for endocarditis. In this retrospective, population-based cohort study of 134 patients with SAB and HVP, 97 patients (72%) were diagnosed with possible endocarditis. Despite that most patients with possible endocarditis received short antibiotic treatment, only 3 patients suffered recurrent SAB.

Cite

CITATION STYLE

APA

Toth, N., Nilson, B., Berge, A., & Rasmussen, M. (2022). Treatment Strategies and Risk of Recurrence in Patients with Heart Valve Prosthesis, Staphylococcus aureus Bacteremia, and Possible Endocarditis - A Retrospective Cohort Study. Open Forum Infectious Diseases, 9(7). https://doi.org/10.1093/ofid/ofac207

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free